Search results
Results from the WOW.Com Content Network
A Maryland firm that oversees the nation’s largest independent network of primary care medical practices is facing a whistleblower lawsuit alleging it cheated Medicare out of millions of dollars ...
Last week, Humana Inc (NYSE:HUM) agreed to pay $90 million to the federal government to settle a whistleblower lawsuit alleging fraudulent Medicare Part D bids. The lawsuit, filed by Phillips ...
A medical billing company owner, Elaine Lovett, of Wayne County, Michigan, was convicted in 2017 for her role in a multimillion-dollar scheme to defraud Medicare using false billing claims, in a ...
Jimmy Carter signs Medicare-Medicaid Anti-Fraud and Abuse Amendments into law. The Office of Inspector General for the U.S. Department of Health and Human Services, as mandated by Public Law 95-452 (as amended), is established to protect the integrity of Department of Health and Human Services (HHS) programs, to include Medicare and Medicaid programs, as well as the health and welfare of the ...
The Judge Donald W. VanArtsdalen of United States District Court ruled that the three had contributed significantly to the Government's case against SmithKline. ordered the government to pay $42.3 million to three men who helped the Justice Department expose Medicare fraud at SmithKline Beecham Clinical Laboratories Inc. [6] [9] The Justice ...
kickbacks/Medicare fraud False Claims Act/FDCA 2003 18 17 Zoladex: AstraZeneca [24] $355,000,000 $266 million ($355 million with criminal component) Medicare fraud Prescription Drug Marketing Act 2006 15 18 Temodar/ Intron A/K-Dur/ Claritin RediTabs: Schering-Plough [25] $435,000,000 $255 million civil ($435 million with criminal component)
For premium support please call: 800-290-4726 more ways to reach us
Vitas “regularly ignored concerns expressed by its own physicians and nurses regarding whether its hospice patients were receiving appropriate care,” the lawsuit alleges. Prosecutors claim the fraud didn’t just occur in that past, but that it is ongoing, with the knowledge of executives at both Vitas and Chemed Corp., the company’s parent.